Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy United-Guardian stock

Own United-Guardian stock in just a few minutes.

United-Guardian, Inc is a household & personal products business based in the US. United-Guardian shares (UG) are listed on the NASDAQ and all prices are listed in US Dollars. United-Guardian employs 22 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in United-Guardian

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – UG – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

United-Guardian share price

Use our graph to track the performance of UG stocks over time.

United-Guardian shares at a glance

Information last updated 2021-04-23.
52-week range$12.71 - $17.46
50-day moving average $14.83
200-day moving average $14.54
Wall St. target priceN/A
PE ratio 21.0988
Dividend yield $0.78 (5.21%)
Earnings per share (TTM) $0.72

Buy United-Guardian shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy United-Guardian stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is United-Guardian under- or over-valued?

Valuing United-Guardian stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of United-Guardian's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

United-Guardian's P/E ratio

United-Guardian's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, United-Guardian shares trade at around 21x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

United-Guardian's EBITDA

United-Guardian's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 million.

The EBITDA is a measure of a United-Guardian's overall financial performance and is widely used to measure a its profitability.

United-Guardian financials

Revenue TTM $11 million
Operating margin TTM 33.1%
Gross profit TTM $6.1 million
Return on assets TTM 18.72%
Return on equity TTM 31.5%
Profit margin 30.08%
Book value $2.25
Market capitalisation $71.8 million

TTM: trailing 12 months

Shorting United-Guardian shares

There are currently 4,791 United-Guardian shares held short by investors – that's known as United-Guardian's "short interest". This figure is 39.6% up from 3,432 last month.

There are a few different ways that this level of interest in shorting United-Guardian shares can be evaluated.

United-Guardian's "short interest ratio" (SIR)

United-Guardian's "short interest ratio" (SIR) is the quantity of United-Guardian shares currently shorted divided by the average quantity of United-Guardian shares traded daily (recently around 8555.3571428571). United-Guardian's SIR currently stands at 0.56. In other words for every 100,000 United-Guardian shares traded daily on the market, roughly 560 shares are currently held short.

However United-Guardian's short interest can also be evaluated against the total number of United-Guardian shares, or, against the total number of tradable United-Guardian shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case United-Guardian's short interest could be expressed as 0% of the outstanding shares (for every 100,000 United-Guardian shares in existence, roughly 0 shares are currently held short) or 0.0015% of the tradable shares (for every 100,000 tradable United-Guardian shares, roughly 2 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against United-Guardian.

Find out more about how you can short United-Guardian stock.

United-Guardian share dividends


Dividend payout ratio: 1.15% of net profits

Recently United-Guardian has paid out, on average, around 1.15% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), United-Guardian shareholders could enjoy a 5.21% return on their shares, in the form of dividend payments. In United-Guardian's case, that would currently equate to about $0.78 per share.

While United-Guardian's payout ratio might seem low, this can signify that United-Guardian is investing more in its future growth.

United-Guardian's most recent dividend payout was on 7 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 29 November 2020 (the "ex-dividend date").

Have United-Guardian's shares ever split?

United-Guardian's shares were split on a 6:5 basis on 11 September 1985. So if you had owned 5 shares the day before before the split, the next day you'd have owned 6 shares. This wouldn't directly have changed the overall worth of your United-Guardian shares – just the quantity. However, indirectly, the new 16.7% lower share price could have impacted the market appetite for United-Guardian shares which in turn could have impacted United-Guardian's share price.

United-Guardian share price volatility

Over the last 12 months, United-Guardian's shares have ranged in value from as little as $12.7091 up to $17.4607. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while United-Guardian's is 0.139. This would suggest that United-Guardian's shares are less volatile than average (for this exchange).

United-Guardian overview

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based cleanser. It also conducts research and development, primarily related to the development of cosmetic ingredients.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site